Study Details
Ruxolitinib Cream for Children with Nonsegmental Vitiligo
(IRB#: IRB_00182881)
Nonsegmental Vitiligo is a skin disease that causes loss of pigment (color) in patches of the skin on the face and body. Ruxolitinib is an approved cream for older children and adults. This study will see how well the cream works for children 2 to 11 years old. Participants will apply the cream at home to treat the areas of skin twice daily for up to 1 year. Being in the study requires attending about 8 in person visits at the study clinic. Medical tests will be done throughout the study to track the health of participants.
- All genders
- Under 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Under 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 2 to 11 years old
- Diagnosis of Nonsegmental Vitiligo
- Must stop using other treatment for vitiligo
- Able to attend in person visits at the study clinic
Exclusion Criteria
- Other forms of vitiligo such as segmental or other skin diseases that impact participation
- Serious illness physical or mental health that impacts full participation
Will I be paid for my time?
Yes
IRB#: IRB_00182881
PI: Jamie Rhoads
Department: DERMATOLOGY
Approval Date: 2025-04-02 06:00:00
Specialties: Dermatology
I am Interested